These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors. Phan AT; Kunz PL; Reidy-Lagunes DL Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956 [TBL] [Abstract][Full Text] [Related]
3. Update in the management of gastroenteropancreatic neuroendocrine tumors. Sedlack AJH; Varghese DG; Naimian A; Yazdian Anari P; Bodei L; Hallet J; Riechelmann RP; Halfdanarson T; Capdevilla J; Del Rivero J Cancer; 2024 Sep; 130(18):3090-3105. PubMed ID: 39012928 [TBL] [Abstract][Full Text] [Related]
4. An update on gastroenteropancreatic neuroendocrine tumors. Cives M; Strosberg J Oncology (Williston Park); 2014 Sep; 28(9):749-56, 758. PubMed ID: 25224471 [TBL] [Abstract][Full Text] [Related]
5. [Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research]. Luley K; Gebauer J; Gebauer N; Tharun L; Buchmann I; Barkhausen J; von Bubnoff N; Lindner K; Keck T; Lehnert H; Schmid SM Internist (Berl); 2020 Aug; 61(8):875-890. PubMed ID: 32676723 [TBL] [Abstract][Full Text] [Related]
6. Will clinical heterogeneity of neuroendocrine tumors impact their management in the future? Lessons from recent trials. Cives M; Soares HP; Strosberg J Curr Opin Oncol; 2016 Jul; 28(4):359-66. PubMed ID: 27138571 [TBL] [Abstract][Full Text] [Related]
7. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy. Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207 [TBL] [Abstract][Full Text] [Related]
8. Gastroenteropancreatic Neuroendocrine Tumors. Cives M; Strosberg JR CA Cancer J Clin; 2018 Nov; 68(6):471-487. PubMed ID: 30295930 [TBL] [Abstract][Full Text] [Related]
9. The emerging role of targeted therapies for advanced well-differentiated gastroenteropancreatic neuroendocrine tumors. Cloyd JM; Konda B; Shah MH; Pawlik TM Expert Rev Clin Pharmacol; 2019 Feb; 12(2):101-108. PubMed ID: 30582383 [TBL] [Abstract][Full Text] [Related]
10. Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract. Cives M; Strosberg J Curr Treat Options Oncol; 2017 Mar; 18(3):14. PubMed ID: 28286921 [TBL] [Abstract][Full Text] [Related]
11. Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature. Neychev V; Kebebew E Int J Surg Oncol; 2017; 2017():6424812. PubMed ID: 28593056 [TBL] [Abstract][Full Text] [Related]
12. Metastatic neuroendocrine tumors of the gastrointestinal tract and pancreas: A surgeon's plea to centering attention on the liver. Keutgen XM; Schadde E; Pommier RF; Halfdanarson TR; Howe JR; Kebebew E Semin Oncol; 2018 Aug; 45(4):232-235. PubMed ID: 30318110 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic characteristics of 127 cases of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) studied in an oncology hospital]. Alvarado-Cabrero I; de Anda-González J; Hernández-Hernández B; Mantilla-Morales A; Valencia-Cedillo R; Medrano-Guzmán R Rev Gastroenterol Mex; 2012; 77(4):174-80. PubMed ID: 23142406 [TBL] [Abstract][Full Text] [Related]
14. [Gastroenteropancreatic neuroendocrine tumor microenvironment and related therapy]. Ye C; Yuan CH; Li G; Zheng L; Xiu DR Zhonghua Wai Ke Za Zhi; 2019 Nov; 57(11):866-871. PubMed ID: 31694137 [TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETs. Prinzi N; Raimondi A; Maccauro M; Milione M; Garanzini E; Torchio M; Corti F; Nichetti F; Lo Russo G; Giacomelli L; Mazzaferro V; Di Bartolomeo M; Seregni E; de Braud F; Pusceddu S Future Oncol; 2019 Sep; 15(26):3015-3024. PubMed ID: 31424273 [No Abstract] [Full Text] [Related]
17. [Chinese expert consensus on gastroenteropancreatic neuroendocrine neoplasms (2022 edition)]. Expert Committee on Neuroendocrine Neoplasms, Chinese Society of Clinical Oncology Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1305-1329. PubMed ID: 36575783 [TBL] [Abstract][Full Text] [Related]
18. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms. Alexandraki KI; Karapanagioti A; Karoumpalis I; Boutzios G; Kaltsas GA Biomed Res Int; 2017; 2017():9856140. PubMed ID: 29349087 [TBL] [Abstract][Full Text] [Related]
19. Management of advanced high grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): comprehensive review of the current literature. Mohamed A; Trybula M; Asa SL; Halfdanarson TR; Sonbol MB Endocr Relat Cancer; 2024 Oct; 31(10):. PubMed ID: 39133180 [TBL] [Abstract][Full Text] [Related]
20. Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion. Yoo C; Oh CR; Kim ST; Bae WK; Choi HJ; Oh DY; Lee MA; Ryoo BY Cancer Res Treat; 2021 Apr; 53(2):291-300. PubMed ID: 33421978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]